Proteomics International Inks Israeli Distribution Deal for Diabetic Kidney Disease Immunoassay – 360Dx

“We believe entering both the European and Middle Eastern markets in recent weeks will drive demand for PromarkerD in 2021 and beyond,” said Richard Lipscombe, managing director of Perth, Australia-based Proteomics International, in a statement.

Article: Proteomics International Inks Israeli Distribution Deal for Diabetic Kidney Disease Immunoassay